Jean Jacques Bienaime - 10 Dec 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
10 Dec 2021
Net transactions value
-$554,820
Form type
4
Filing time
17 Dec 2021, 18:03:34 UTC
Previous filing
22 Oct 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Gift $0 -700 -0.23% $0.000000 303,689 10 Dec 2021 Direct F1
transaction BMRN Common Stock Options Exercise $224,760 +6,000 +2% $37.46 309,689 15 Dec 2021 Direct F2
transaction BMRN Common Stock Sale $496,260 -6,000 -1.9% $82.71 303,689 15 Dec 2021 Direct F2
transaction BMRN Common Stock Options Exercise $224,760 +6,000 +2% $37.46 309,689 16 Dec 2021 Direct F2
transaction BMRN Common Stock Sale $508,080 -6,000 -1.9% $84.68 303,689 16 Dec 2021 Direct F2
holding BMRN Common Stock 247,533 10 Dec 2021 Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6,000 -4.4% $0.000000 131,000 15 Dec 2021 Common Stock 6,000 $37.46 Direct F2, F3
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6,000 -4.6% $0.000000 125,000 16 Dec 2021 Common Stock 6,000 $37.46 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 10, 2021 the reporting person gifted 700 shares to an educational institution.
F2 Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.
F3 Reflects the number of options outstanding after the transactions from this specific stock option grant.